Navigation Links
Osteotech's MagniFuse(TM) Distributed to 68 U.S. Hospitals as Product Revenue Surpasses $1 Million
Date:3/8/2010

tions for regenerative medicine to support surgeons and their patients through the development of innovative therapy-driven products that alleviate pain, promote regenerative and biologic healing and restore function.  For further information regarding Osteotech or this press release, please go to Osteotech's website at www.osteotech.com.

Certain statements made throughout this press release that are not historical facts are forward-looking statements (as defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company's ability to develop and introduce new products, differences in anticipated and actual product and service introduction dates, the ultimate success of those products in the marketplace, the continued acceptance and growth of current products and services, the impact of competitive products and services, the availability of sufficient quantities of suitable donated tissue and the success of cost control and margin improvement efforts. Certain of these factors are detailed from time to time in the Company's periodic reports filed with t
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Osteotechs MagniFuse(TM) Technology Used in First U.S. Surgery
2. Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting
3. OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Alabama Hospitals Compare Infection Prevention Performance Statewide With New Benchmarking Tool
6. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
7. Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection
8. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
9. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
10. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
11. CDC Analysis Finds Unique Social and Behavior Intervention Helps Reduce MRSA Rates Up to 62% in Study Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... SAN DIEGO , July 1, 2015  AVACEN, Inc. ... a second AVACEN patent covering the medical technology platform supporting ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... The apparatus and methods patent no. 9,066,781 - Methods And ... devices manufactured by AVACEN and specific methods of use, referred ...
(Date:7/1/2015)... July 1, 2015   Continental Clinical Solutions (Continental) announced it is expanding its ... to accommodate increased volume in clinical studies and demand for unique patient populations.  ... ... ... ...
(Date:7/1/2015)... 2015  BioPharmX Corporation (NYSE MKT: BPMX) today announced ... of 3,636,364 shares of its common stock at a ... has granted the underwriters a 30-day option to purchase ... the public offering price. In addition, Korea ... has agreed to purchase 1,081,081 shares of common stock ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3
... Solutions Development Company (MSDC), a drug discovery and ... metabolic diseases, announced today that it has launched ... second drug candidate for the treatment of type ... placebo-controlled clinical trial will involve approximately 125 patients ...
... SAN and NYSE: SNY ) announced today ... Rights (CVRs) offered to Genzyme shareholders as part of ... by the U.S. Securities and Exchange Commission. ... Genzyme, sanofi-aventis has commenced an exchange offer to acquire ...
Cached Medicine Technology:Metabolic Solutions Development Company Launches Phase 2a Trial of Its Second Compound to Treat Type 2 Diabetes 2Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective 2Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective 3
(Date:7/1/2015)... New York, New York (PRWEB) , ... July ... ... drug injury lawsuit filed against the manufacturers of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has ... the U.S. District Court, Southern District of West Virginia on June 26th, the ...
(Date:7/1/2015)... ... July 01, 2015 , ... For decades, researchers in the genetics field have ... the brain, never changing after development in the womb. Now, researchers from the Icahn ... brain cells throughout life – a process which helps to switch genes on and ...
(Date:7/1/2015)... ... July 01, 2015 , ... There ... liberty. Americans have been arguing over laws governing sexuality since the first Pilgrims ... a forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker ...
(Date:7/1/2015)... New York, NY (PRWEB) , ... July 01, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – today announced that they will welcome four new members to ...
(Date:7/1/2015)... Allen, TX (PRWEB) , ... July 01, 2015 ... ... designed for retail, long term care, specialty, combo, and compounding pharmacy operations, announces ... upcoming attendance to the Cardinal Health RBC event at the Venetian ...
Breaking Medicine News(10 mins):Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4
... The Obesity Action,Coalition (OAC) is calling on the state ... (HB 282) that discriminates,against those affected by obesity by ... feels that HB 282 is outright discrimination,against the obese ... to address the obesity epidemic., Introduced in late ...
... Association (APHA) today released its annual congressional record,which measures ... to public health., APHA,s report was compiled by ... votes during the first session of the 110th,Congress in ... senators voted in support of APHA,s,position on all eight ...
... (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth ... which demonstrated that ENBREL reduced C-reactive protein (CRP), a ... plaque psoriasis following 12 weeks of treatment. Median ... the ENBREL treated group compared to the placebo treated ...
... River Expansion ... Despite CP,s Declared Uncertainty, ROCHESTER, Minn., Feb. 1 ... require mitigation for,the city of Rochester as a condition of ... Railroad (DM&E). The,proposed merger currently ignores the significant environmental impacts,created ...
... Clinton,Campaign today announced the endorsement of the American ... the nation,s 2.9 million,registered nurses., "Too many ... and this,country deserves a president that will make ... M. Patton, MSN, RN, CNOR. "Senator,Clinton has shown ...
... screenings offered to encourage healthy hearts, GLEN BURNIE, ... Baltimore Washington Medical Center has the key,to a healthier ... The medical center will host the fourth annual Day ... 10 a.m. to 3 p.m. at the Severna Park,Community ...
Cached Medicine News:Health News:Obesity Action Coalition Calls on the State of Mississippi House of Representatives to Withdraw House Bill 282 Discriminating Against Those Affected by Obesity 2Health News:APHA Scores Members of Congress on Public Health Voting Record 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 3Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 4Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 5Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 2Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 3Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 4Health News:The American Nurses Association Endorses Senator Hillary Rodham Clinton (D-NY) 2Health News:Baltimore Washington Medical Center Hosts Day of Dance for Health 2
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
... over a wide range of concentration, ... more thorough characterization than other methods. ... relative change in the distribution of ... to measure heterogeneity, stoichiometry and self-associating ...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
Medicine Products: